We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+29.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.47B
AUM Growth
+$451M
Cap. Flow
+$1.13B
Cap. Flow %
11.96%
Top 10 Hldgs %
21.59%
Holding
903
New
107
Increased
255
Reduced
393
Closed
103

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$51.9M
2
MRK icon
Merck
MRK
+$50.9M
3
DHR icon
Danaher
DHR
+$45.3M
4
TMO icon
Thermo Fisher Scientific
TMO
+$37.8M
5
JD icon
JD.com
JD
+$37.7M

Sector Composition

Rank Sector Weight
1 Healthcare 34.61%
2 Technology 20.94%
3 Consumer Discretionary 8.9%
4 Financials 8.59%
5 Communication Services 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WPC icon
501
W.P. Carey
WPC
$16.8B
$1.61M 0.02%
13,318
-5,065
-28% -$315K
VRSN icon
502
VeriSign
VRSN
$25.4B
$1.61M 0.02%
7,799
-888
-10% -$184K
NVO
503
Novo Nordisk
NVO
$225B
$1.61M 0.02%
49,206
+3,048
+7% +$97.3K
DOV icon
504
Dover
DOV
$27.4B
$1.61M 0.02%
16,661
-1,216
-7% -$112K
XLNX
505
DELISTED
Xilinx Inc
XLNX
$1.6M 0.02%
16,300
-13,690
-46% -$1.21M
SPG icon
506
Simon Property Group
SPG
$76.8B
$1.59M 0.02%
23,299
-10,129
-30% -$635K
GLW icon
507
Corning
GLW
$108B
$1.57M 0.02%
+60,688
New +$1.38M
NVR icon
508
NVR
NVR
$17.3B
$1.56M 0.02%
205
-122
-37% -$374K
YUM icon
509
Yum! Brands
YUM
$41.4B
$1.54M 0.02%
17,759
-10,265
-37% -$877K
MPC icon
510
Marathon Petroleum
MPC
$89.3B
$1.53M 0.02%
40,983
-24,216
-37% -$778K
HAL icon
511
Halliburton
HAL
$26.1B
$1.53M 0.02%
117,698
+28,950
+33% +$312K
ADM icon
512
Archer Daniels Midland
ADM
$40.1B
$1.5M 0.02%
37,704
-18,854
-33% -$706K
CF icon
513
CF Industries
CF
$18.9B
$1.5M 0.02%
53,203
-46,977
-47% -$1.34M
KHC icon
514
Kraft Heinz
KHC
$32.4B
$1.49M 0.02%
46,704
-37,070
-44% -$1.11M
BF.B icon
515
Brown-Forman Class B
BF.B
$13.3B
$1.48M 0.02%
23,173
-2,907
-11% -$185K
ARE icon
516
Alexandria Real Estate Equities
ARE
$9.41B
$1.47M 0.02%
9,041
-1,418
-14% -$217K
CFG icon
517
Citizens Financial Group
CFG
$30.8B
$1.45M 0.02%
57,510
-165,958
-74% -$3.77M
BBD icon
518
Banco Bradesco
BBD
$38.3B
$1.44M 0.02%
456,729
-62,027
-12% -$189K
WAT icon
519
Waters Corp
WAT
$37.7B
$1.44M 0.02%
7,963
-178
-2% -$33.6K
SWKS icon
520
Skyworks Solutions
SWKS
$9.73B
$1.42M 0.02%
11,136
-23,236
-68% -$2.57M
APO icon
521
Apollo Global Management
APO
$71.9B
$1.42M 0.02%
28,475
+14,580
+105% +$640K
RIO icon
522
Rio Tinto
RIO
$149B
$1.42M 0.02%
+25,220
New +$1.28M
OKTA icon
523
Okta
OKTA
$23.7B
$1.41M 0.01%
7,037
-1,094
-13% -$186K
ALGN icon
524
Align Technology
ALGN
$12.6B
$1.41M 0.01%
5,132
-1,259
-20% -$284K
CMG icon
525
Chipotle Mexican Grill
CMG
$43B
$1.4M 0.01%
66,650
-29,100
-30% -$539K

Similar funds

Candriam SCA's Q2 2020 Portfolio in Review

As of Q2 2020, Candriam SCA held 903 positions worth $9.47B, up 5% from $9.02B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $1.13B of net new capital in Q2 2020, opening 107 new positions and adding to 255 existing holdings. Its largest new stake was JD.com: 744,410 shares worth $44.8M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $103M trimmed.

  • Candriam SCA's largest Q2 2020 buy was JD.com: 744,410 shares worth $44.8M.
  • Candriam SCA added most to Blueprint Medicines in Q2 2020, an estimated $51.9M increase.
  • Candriam SCA's biggest Q2 2020 reduction was Regeneron Pharmaceuticals, cutting an estimated $103M.
  • Candriam SCA fully exited Salesforce in Q2 2020, selling an estimated $62.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $9.47B portfolio in Q2 2020.
  • Candriam SCA opened 107 new positions and closed 103 in Q2 2020.
  • Candriam SCA's portfolio value rose 5% quarter-over-quarter to $9.47B.

Based on Candriam SCA's 13F filing for Q2 2020, filed 23 Jul 2020.